Other GLP-1 Analogs: Short-Acting vs Long-Acting After exenatide and liraglutide, several other GLP-1 receptor agonists were introduced in the early-to-mid 2010s
In April, Reilly took her first shot of Zepbound
Our comprehensive follow-up program includes quarterly check-ins with providers, nutritional counseling between appointments, and personalized exercise guidance
Oral GLP-1 options, next-generation compounds targeting different pathways, and eventually generic versions of current products will create new pricing leverage
Heres who usually benefits from microdosing: Full-dose tirzepatide can be effective, but its not for everyone
See full terms here Protected, private, and secure Pricing Exceptional care, made easier to access Mochi membership brings together provider access, coaching, support, and treatment options in one guided experience